Company profilePharmaceutical#225 of 1,318 in Pakistan✓ No DRAP alerts

FERROZA INTERNATIONAL PHARMACEUTICALS (PVT) LTD.

Pharmaceutical company · 80 brands · 72 molecules

Ranked #32 of 311 companies in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord)

80 registered products 29 pharmaceutical brands 72 distinct molecules 0 DRAP alerts

Company overview

80
registered products
29
pharmaceutical brands
72
distinct molecules
12
therapeutic classes
0
DRAP alerts

FERROZA INTERNATIONAL PHARMACEUTICALS (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 80 product registrations across 72 distinct molecules. Its portfolio is concentrated in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) and Quinolone Antibacterials. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Diclofenac4 brands
Esomeprazole3 brands
Paracetamol3 brands
Omeprazole3 brands
Gabapentin2 brands
Gatifloxacin2 brands
Amoxicillin2 brands
Fexofenadine2 brands
Ampicillin2 brands

Therapeutic classes

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 7Quinolone Antibacterials · 4Antiepileptics · 3Other Beta-Lactam, Cephalosporins & Penems · 3Antithrombotic Agents · 2Lipid Modifying Agents · 2Antiobesity Preparations · 1Antispasmodic & Anticholinergic · 1Antidiarrheals, Intestinal Antiinflammatory/Antiinfective · 1Anti-Infectives · 1Ace Inhibitor · 1Beta Blocking Agent · 1

Conditions treated

General Infections · 1

Price band (DRAP official ceilings)

Registered products priced by source
Servaid1 products · Rs 180 – Rs 180
Median across source: Rs 180

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Get the full profile for FERROZA

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.